ArticleBlood advances2021

Activity of blinatumomab in lymphoblastic leukemia with impaired T-cell immunity due to congenital immunodeficiency.

Sandheeah Ramdeny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.